Litigation Details for Salix Pharmaceuticals Inc. v. Novel Laboratories Inc. (D. Del. 2015)
✉ Email this page to a colleague
Salix Pharmaceuticals Inc. v. Novel Laboratories Inc. (D. Del. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-01-08 |
| Court | District Court, D. Delaware | Date Terminated | 2017-07-31 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Patents | 6,551,620; 8,337,886; 8,496,965; 8,865,688 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Salix Pharmaceuticals Inc. v. Novel Laboratories Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Salix Pharmaceuticals Inc. v. Novel Laboratories Inc. (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2015-01-07 | 1 | United States Patent Numbers 6,551,620 (“the ’620 patent”), 8,337,886 (“the ’886 patent”), 8,496,965 …Bases for NOVEL’S Certification That U.S. Patent Nos. 6,551,620 B2, 8,337,886 B2, and 8,496,965 B2 are …’965 patent”), and 8,865,688 (“the ’688 patent”) (collectively, “the Orange Book-listed patents”). …is an action for patent infringement arising under the food and drug laws and patent laws of the United… THE PATENT IN SUIT 12. Falk is the owner by assignment of the ’688 patent, entitled | External link to document | |
| 2015-01-07 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) us 8,865,688;. (mas) (Entered:…2015 31 July 2017 1:15-cv-00027 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
